Market Research Blog

According to latest research by FMI, the global disposable spinal instruments market is estimated to have accounted for US$ 43.7 Mn in terms of value in 2021. The report on the disposable spinal instruments market further projects that the disposable spinal instruments market is likely to grow at a CAGR of 8.2% during the period 2022-2029.

Healthcare-Associated Infections or Hospital-Acquired Infections (HAIs) are caused while receiving medical treatment in a hospital facility. HAIs are among the major challenges to the safety of patients, and can have severe public health implications. These infections are also capable of causing disability and sometimes death. The occurrence of HAIs is increasing at an alarming rate. According to WHO, the prevalence of these infections in developed countries varies from 3.5% to 12%. Developing countries are at a higher risk as the rate of infection is 3-20 times higher in developing countries as compared to high-income countries.

In the U.S., more than 15 Mn surgeries are performed annually. Between 2% and 5% of patients are estimated develop a surgical site infection, which is between 160,000 and 300,000 surgical site infections nationwide each year. Surgical site infections are among the most commonly occurring HAIs in the U.S., and are the most expensive to treat. Fortunately, the adoption of various disposable devices and kits has reduced the incidence of surgical site infections and HAIs.

Thus, the increasing preference for the usage of disposable instruments for reducing the occurrence of HAIs is driving the demand for disposable instruments, which is creating growth opportunities for the disposable spinal instruments market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-6890

The demand for disposable instruments kits in the healthcare industry is growing at a significant rate, and the demand from unconventional end-use industries is one of the major factors fuelling the market for disposable spinal instruments. Growth in the number of end users, apart from hospitals, such as orthopaedic clinics and Ambulatory Surgical Centres (ASCs), is expected to create high demand for disposable spinal instruments. Moreover, the adoption of disposable instrument kits by various end users has reduced the risk of infections and cross-contamination, which has resulted in a reduction in the number of HAIs.

Increase in the number of use cases of disposable spinal instruments in hospitals and ASCs is expected to boost the global demand for disposable instrument kits. According to CDC, the number of Medicare-certified ASCs has increased steadily from 239 in 1983 to 5,316 in 2010.

Moreover, increasing geriatric population, which is prone to various types of spinal injuries, is estimated to boost the need for surgeries. This is expected to contribute to the demand for disposable spinal instruments. The increasing requirement of instrument kits during surgeries among the greying population, coupled with improved life expectancy, has created significant growth opportunities for the manufactures of disposable spinal instruments market. However, factors such as stringent regulations and the generation of a significant amount of waste due to the usage of disposable kits is expected to lower the growth of disposable spinal instruments in the forecast period.

The disposable spinal instruments kits segment is a leading segment in terms of revenue by product type in the disposable spinal instruments market, with a 64.5% revenue share in 2021. These kits are most widely used in cervical and lumbar surgeries such as spinal fusion and decompression surgeries. Among the procedure type segments, the spinal fusion sub-segment accounts for the largest revenue share in the disposable spinal instruments market. Among all the end users in the disposable spinal instruments market, the hospitals sub-segment is expected to be a prominent segment, followed by the orthopaedic clinics sub-segment.

The disposable spinal instruments market has been analysed across the regions of North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA. North America, followed by Europe, is a prominent region in the global disposable spinal instruments market. North America accounted for a revenue share of 45.8% in 2021 in disposable spinal instruments market. Europe, accounting for the second-largest revenue share, is followed by East Asia in the disposable spinal instruments market. India, China, and Brazil are emerging markets in the disposable spinal instruments market. China is one of the fastest-growing emerging markets in the global disposable spinal instruments market, and is projected to grow at a CAGR of 11.2% over the forecast period of 2022-2029.

The disposable spinal instruments market report tracks some of the key companies operating in the disposable spinal instruments market, such as ECA Medical, Providence Medical Technology, Inc., Xenco Medical, Paradigm Spine, Intelligent Implant Systems, LLC, Safe Orthopaedics, SA , TeDan Surgical Innovations, LLC, and Joimax GmbH. Majority of the regional players in the disposable spinal instruments market are focused on increasing their product reach and connectivity with the regional distributors of disposable spinal instruments. The manufacturers of disposable spinal instruments are focusing on collaborating with established hospitals and ASCs to sell products as some of the medical practitioners are particular about the type and brand of products used for a surgical procedure.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-6890

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Remarkable increase in the companion animal ownership and strong growth of development of the veterinary healthcare infrastructure collectively push the sales of companion animal vaccines in global market. Surpassing the revenues worth US$ 2.5 Bn in 2021, global companion animal vaccines market is projected to exhibit a robust CAGR during 2022 – 2029. Measurable rise in the zoonotic disease prevalence will remain a key factor fueling the demand for companion animal vaccines and drugs.

FDA approvals for novel and innovative companion animal vaccines continue to present potential growth opportunities to R&D of companion animal vaccines. For instance, Zoetis received regulatory approval for ProHeart, used for prevention of heartworm diseases caused by Dirofilaria immitis in dogs.

Key Takeaways – Companion Animal Vaccines Market Study

• Attenuated live vaccines currently account for more than a third of total market value, and will continue to witness a healthy CAGR through 2029. This demand growth is attributed to their improved effectivity and enhanced long-term preventive action.
• North America is witnessing lucrative market growth compared to other regions attributed to increase in the adoption rate of companion animals, increase in veterinary healthcare expenditure, and increasing awareness about pet health.
• Veterinary animal hospitals and clinics offering better service support for animal care are expected to  have  significant market share during the forecast period
• As large number of people are in close contact with canine animals as a preference for companion animal, demand will be prominent among canine species.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1427

Increasing R&D Investments to Widen Market Growth Prospects

Elanco, Ceva Sante Animale, Boehringer Ingelheim are among the leading market players in the companion animal vaccines market. These manufacturers continue to dominate the market landscape of companion animal vaccines by investing heavily in R&D activities to develop and launch therapeutic vaccines for prevention and treatment of various animal diseases. Surge in investment for R&D of vaccines, which inhibit the growth of antibiotic-resistant organisms boosts the animal vaccines market growth.

For instance, in August 2021, Elanco invested two-thirds of the budget for food‐animal unit to develop vaccines and reduce the use of antibiotics. Moreover, rise in demand for animal vaccines led to the development of multiple new vaccines. For instance, Cevac IBron a new vaccine was launched by Ceva in February 2017 for prevention against infectious bronchitis virus (IBV) in animals.

Know More About Companion Animal Vaccines Market Report

Future Market Insight brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2029. The global companion animal vaccines is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights of the companion animal vaccines market on basis of product type (attenuated live vaccines, conjugated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, recombinant vaccines), species type (canine, avian, feline) and distribution channel (companion animal hospitals, companion animal hospitals, companion animal research institutes) across seven major regions.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1427

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

The global demand for venous thromboembolism treatment market is likely to grow steadily over the forthcoming years. As indicated by a recent Future Market Insights (FMI) study, the market revenues will observe approximately 3.7% CAGR between 2022 and 2029.

More than 3/5^th of treatment demand is underpinned by deep venous thrombosis, according to the report. Catheter-directed thrombolysis devices and percutaneous thrombectomy devices, collectively account for more than half of the global revenues represented by the venous thromboembolism treatment market.

Venous thromboembolism treatment involves segmented pneumatic compression pumps without gradient, segmented pneumatic compression pumps with calibrated gradient, lower pneumatic compression sleeves, non-segmented pneumatic compression pumps permanent inferior vena cava filters, retrievable inferior vena cava filters, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (CDT) devices and upper pneumatic compression sleeves. Based on the disease indication, deep vein thrombosis is expected to hold a prominent share in the overall venous thromboembolism treatment market.

Poor Reimbursement Scenario Against High Treatment Costs to Restrict Adoption

Several factors are impacting the overall growth of the venous thromboembolism treatment market. The first and the most important factor driving the venous thromboembolism treatment market is the increasing prevalence of venous thromboembolism disease. Other factors, such as the increasing retrieval rate of vena cava filters, increasing healthcare awareness, presence of favourable reimbursement policies, and increasing geriatric population, are also responsible for the growth of the venous thromboembolism treatment market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1341

Apart from the driving factors of venous thromboembolism treatment market, there are few factors that are likely to hinder the overall growth of the venous thromboembolism treatment market. The high cost associated with venous thromboembolism treatment therapy, poor reimbursement for some of the treatment devices, and poor insurance support are among the major factors that are expected to hamper the growth of the venous thromboembolism treatment market.

Drug-based Treatment Witnessing Traction across Europe

Although increasing preference for drug-based venous thromboembolism treatment is highly likely to hinder the growth of the market, new-generation drugs, including non-Vitamin K antagonist oral anticoagulants (NOACs) such as dabigatran, rivaroxaban, apixaban, and edoxaban, are estimated to boost the adoption rate of venous thromboembolism treatment due to increased efficacy. However, there are regional variations to this trend.

North America is expected to be a prominent region in the global venous thromboembolism treatment market because of the presence of a well-developed healthcare infrastructure and numerous technological advancements in the region. The increasing prevalence of venous thromboembolism is also responsible for the boosting the growth of the North America market. Treatment using mechanical and interventional prophylaxis systems is expected to be increasingly adopted in the North American region during the forecast period. In addition, drug-based treatment is expected to gain popularity in the European region, which is expected to subsequently decrease the usage of mechanical and interventional treatments in the region.

On the other hand, increasing per capita healthcare expenditure is one of the macroeconomic factors that is likely to boost the market. Nowadays, certain changes in the socio-economic scenario can also lead to significant growth in the venous thromboembolism treatment market.

Tier 1 Players Account for Nearly 35% Market Revenue Share

Some of the key manufacturers of venous thromboembolism treatment are mainly focusing on innovating and launching new and advanced products. Major players in the venous thromboembolism treatment market are focusing on collaborations and acquisitions. For example, venous thromboembolism treatment is majorly adopted by hospitals, catheterisation laboratories, and ambulatory surgical centres. Hospitals are expected to hold a significant revenue share in the venous thromboembolism treatment market.

The report tracks some of the key companies operating in the venous thromboembolism treatment market such as ArjoHuntleigh AB, AngioDynamics, Cardinal Health Inc., BTG International Ltd., Stryker Corporation, DJO Global Inc., EKOS Corp, and Teleflex Inc., Boston Scientific Corp.  There are several other companies operating in the venous thromboembolism treatment market. AngioDynamics, Boston Scientific Corp., and Cardinal Health Inc. are expected to hold a prominent share in the venous thromboembolism treatment market. These tier 1 companies hold a share of approximately 35% in the venous thromboembolism treatment market.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1341

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

According to the latest research by the FMI, the global urology imaging systems market is expected to account for over US$ 486.4 Mn, in terms of value, by 2028 end. The report on the Urology Imaging Systems market further projects substantial growth potential with CAGR of 3.7% over 2022-2028.

While hospitals will continue to register the highest revenue share in terms of urology imaging systems adoption, the report highlights limited investment opportunities for manufacturers of urology imaging systems, within clinics.

Increasing EU Reserve Funding Encouraging Adoption of Urology Imaging Systems

Increasing instances of urological disease and simultaneously increasing awareness about critical health issues is anticipated to boost demand for urology imaging systems and services across globe. Accessibility of EU reserves for part states in the CEE, paralleled by administrative projects in Russia, will be an imperative source of financing for new imaging equipment purchases and will contribute fundamentally to the advancement of the urology imaging systems market in the Eastern Europe.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-8911

In Russia, the 2020 Healthcare Development Program and National Project ‘Health’ center not just around conveying propelled advances to the nation and furnishing healthcare facilities with costly, top of the line urology imaging systems, yet additionally on obtaining mid-range and low-end urology imaging systems that are very required in local health facilities. The compliance to the EU reserve funding has given access to countries like the Czech Republic, Hungary, Poland, Bulgaria and Romania. Such compliances are anticipated to eliminate barriers for the new entrant in urology imaging systems market.

The growing demand for urology imaging systems is centered at increasing inclination towards technologically-advanced imaging tools used in the diagnosis of prostate cancer and uterine fibroid to reduce the risk of uterine cancer. Further increasing demand for urology imaging systems for accurate diagnosis and second opinion is anticipated to create demand for ultrasound- as well as fluoroscopy-based urology imaging systems, thereby driving the growth of the Urology Imaging Systems market. However, ultrasound systems are likely to continue representing a larger market value share over fluoroscopic variants, according to FMI’s analysis.

Favorable Reimbursement Scenario, Supported by Increasing Number of Diagnostic Establishments Driving Market Growth

In the recent years, the number of independent diagnostics and imaging centers in various developed and developing regions has seen a significant spike, overcoming a series of volume and reimbursement pressures in an effort to sustain profitability and achieve better margins. This according to the report is expected to drive the growth of the Urology Imaging Systems market.

Many insurance companies have adopted effective marketing strategies to shift the patient volume to low-cost independent diagnostic centers and reduce the price point associated with urology imaging systems. Independent diagnostic imaging centers offer better service and often of superior quality, generally at the expense of local hospitals and weak operators. The development of low cost portable urology imaging systems is providing leverage to current imagining centers and subsequently driving the growth of Urology Imaging Systems market.

The report tracks strategic developments of some of the prominent players competing in  the global urology imaging systems market, including GE Healthcare, Toshiba Medical, Philips Healthcare, Hitachi-Aloka Medical, Siemens Healthineers, Samsung Medison, Mindray, Fujifilm Sonosite, Esaote, and Analogic. The report also provides key aspects and trends in the Urology Imaging Systems market, including reimbursement scenario, average selling price, and country-wise revenue analysis.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-8911

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Worldwide sales of surgical tourniquets will increase by 7.5% year-over-year to reach ~US$ 481 million in 2022, up from ~US$ 444.5 million in 2021, according to the latest research from Future Market Insights (FMI).

FMI’ analysis expects the surgical tourniquets market to grow at ~7.8% CAGR through to 2029, driven a surge in the number of trauma cases over the years lined with rising demand for effective device to stop arterial bleeding during surgical procedures. Analysts also expect that automatic machines and robotic technologies are likely to bring a paradigm shift in operative procedures, which should push the manufacturers to innovate their products and develop strategies to attract and retain a new segment of customers.

In an attempt to reduce the risks associated with higher tourniquet pressures, manufacturers are placing their bets on products innovations and introduction of novel features such as automatic pressure control, audiovisual alarms, digital displays, and easy-to-use user interface.

Sales of Tourniquet Cuffs to Ramp up in 2022

According to the FMI analysts, tourniquet cuffs have been a vital part of the modern computer-assisted tourniquet system, which accounted for ~77% of total market revenue in 2021. While the inflatable disposable cuffs represented more than half of the total tourniquet cuff sales in 2021, the consumption of inflatable reusable cuffs is likely to increase 7.6% y-o-y in 2022.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-2254

“In terms of tourniquet systems, dual channel systems will continue to represent a relatively high share as compared to single channel systems, in the view of enabling bi-lateral procedures or simultaneous surgeries of both upper and lower extremity,” the FMI analyst said.

The consumption of surgical tourniquets for knee arthroplasty accounted for ~31% sales in 2021, while increasing application in amputation of limbs and trauma cases is likely to result in increased market share in the future.

“Recent advancements in reverse shoulder arthroplasty along with the introduction of ‘personalized’ tourniquet systems that allow the use of variable contour design and cuffs for specific patients will open new avenues of growth for the market players,” said the FMI analyst.

Hospitals Capture Significant Share, North America in the Vanguard

In 2018, surgical tourniquets worth ~US$ 176 million were sold in hospitals; according to the FMI analysts, growing number of hospitals, especially in developing countries, and greater awareness of advanced medical devices will continue to drive the consumption of surgical tourniquets in hospitals.

Rapid adoption of ‘value-based’ model in health care settings have led to a surge in the number of ambulatory surgical centers and specialized clinics, thereby paving a new way of growth for the surgical tourniquets market.

The FMI analyst forecasts that North America will continue to remain at the forefront of surgical tourniquets market, representing 30% share in 2021. While North America is likely to be neck-and-neck with Europe to lead the market in future, manufacturers are tapping into new opportunities in developing countries in Asia Pacific.

The surgical tourniquets market shows a fair level of fragmentation, with two prominent players including Zimmer Biomet and Stryker Corporation accounting for more than one-third of the total revenue share. Exploring unmet needs in developing regions and expanding their distribution through collaboration and acquisitions of local and regional manufacturers remain key focal points of the market players.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-2254

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

According to a new market research report by Future Market Insights, the global cotinine screening devices market was valued at ~US$ 429.9 Mn in 2021, and is expected to increase at a CAGR of ~4.7% during the forecast period of 2022-2029. The report scrutinizes the cotinine screening devices market and provides critical insights for the forecast period of 2022-2029. As per the findings of the report, the global cotinine screening devices market is projected to experience a significant growth over the forecast period, which will be set in motion by a slew of factors such as growing focus on ‘value-driven’ healthcare services and high demand for effective screening techniques.

Developing Markets to Reflect New Growth Possibilities

Regions such as North America and Europe are expected to hold prominent market share in terms of value. However, developing markets are expected to project lucrative growth in the global cotinine screening devices market in the forecast period of 2022-2029. The exponential rise in workplace screening is one of the key drivers laying new growth alleys for manufacturers of cotinine screening devices to reap benefits from. The economic and technological parity of developing regions with the developed ones is another chief factor estimated to generate steady sales revenue for market players of cotinine screening devices.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-8472

Furthermore, rising level of awareness and adoption of products useful in smoking cessation programs is further upholding the lucrativeness of developing markets such as China, India and Brazil. The factors such as growing prevalence of smoking, screening employees for illicit drugs, sporting events, and deciding the health plan premium are anticipated to surge the sales of cotinine screening devices in developing counties.

The burgeoning middle-class population along with multiple compliances created for recruitment in the armed forces are anticipated to increase the potential use cases of cotinine screening devices in 2022 and beyond. The contract manufacturing services available in developing markets coupled with cheap labor force are expected to boost the investment and attractiveness quotient of developing countries, making them no less than hotbeds of opportunities for growth.

End Users to Show Marked Preferences for Cassettes

By device type, the cassettes are expected to hold prominent value shares of the global cotinine screening devices market. This has majorly resulted from the cost effectiveness, ease of screening, quick detection, and portability of these compact cotinine screening devices. The report features the prominent players in the cotinine screening devices market, whose success has been riding on their strong portfolios and regional presence.

The global cotinine screening devices market is significantly consolidated with a chunk of players commanding prominent shares of the market. These players are offering cotinine screening devices under their popular brands such as Accutest®, ALERE ISCREEN®, Reditest®, QuickProfile™, NicCheck™ I, DrugCheck® SalivaScan™, TobacAlert®, among others.  Mergers and acquisitions will remain one of the key part of the growth & expansion strategies of cotinine screening devices market players, with an extensive emphasis on creating newer business models as well as distribution channels.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-8472

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Rapid expansion of wound management space has argued well for the growth in demand for tissue engineered skin substitutes. The global tissue engineered skin substitute market is projected for a robust 9.6% CAGR during 2022 – 2029, predominantly driven by high applicability in diabetic foot ulcers and other chronic wounds.

With advent of tissue engineering and improved ability to combine advanced manufacturing technologies with biomaterials and cell culture systems, more biomimetic tissue constructs have been emerged. Technological advancements are leading to production of advanced tissue engineered skin substitutes. 3D bioprinting and biotextile are emerging as popular biofabrication strategies for creating bioengineered skin substitutes. A team of researchers in the U.S. recently discovered a technology for complete 3D printing of the living skin along with blood vessels. Emergence of such revolutionary fabrication technologies will create a massive opportunity in the global market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-781

Key Takeaways – Tissue Engineered Skin Substitute Market Study

• With increasing researches in tissue engineering, the demand for   biologic skin substitute is expected to increase in the forecast period. For instance, a team of engineers at the California Institute of Technology (Caltech) and ETH Zurich have developed an artificial skin made from pectin, a naturally occurring long-chain molecule present in plant cell walls allowing the construction of natural and new dermis.
• Increasing prevalence of diabetes and chronic wounds is boosting the demand for tissue engineered skin substitutes.
• The demand for tissue engineered skin substitutes in emerging economies such as China and India is expected to increase owing to increasing incidence of diabetic foot ulcers, venous leg ulcers, and pressure ulcers.

Leading Manufacturers Setting the Pace for Product Innovations

The tissue engineered skin substitute market is a consolidated market. The tier 1 companies in the tissue engineered skin substitute market such as Allergan Plc., Mimedex Group Inc., Integra LifeSciences Corp. and Integra LifeSciences Corp. are expected to hold more than half of the total revenue generated by tissue engineered skin substitutes. The key players in the market are reshaping their current product portfolio by focusing on the introduction of new and advanced technologies and innovating new products.

Seeking More Insights?

Tissue engineered skin substitute market, a new study from Future Market Insights, opines on the evolution of tissue engineered substitute market from 2014 – 2021 and presents demand projections from 2022 – 2029 on the basis of; product (acellular skin substitute, biologic skin substitute, cellular skin substitute and synthetic substitute), material (synthetic and natural), application (chronic wound, acute wound and other applications such as breast reconstruction etc.) and end user (hospital, specialty clinics, ambulatory surgical centres and research laboratories) across seven prominent regions.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-781

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Implantable drug-eluting devices are playing a key role in the management and treatment of various chronic disorders, particularly cardiovascular diseases. Advancements in micro and nanotechnology are aiding key manufacturers to design novel implantable drug-eluting devices.

Moreover, controlled and site-specific attributes of implantable drug-eluting devices, further complemented by compatibility with the targeted drug delivery, are relieving the burden of complex dosing schedule and systemic toxicity of conventional drug delivery system. The global implantable drug-eluting devices market is projected to cross the US$ 10 Bn mark towards the end of 2022. Market leaders in implantable drug-eluting devices landscape are maintaining their focus on refining manufacturing processes.

Remote-Controlled Chips and Programmable Devices – Future of Targeted Drug Delivery

Increasing clinical trials and research & development of remote-controlled and programmable drug-eluting devices

Massachusetts Institute of Technology (MIT) researchers have developed a remote-controlled contraceptive hormone (levonorgestrel) delivery chip implant, which can turn the device on and off.

Implantable drug-eluting devices allow minimum effective doses and support oral opioid weaning

Implantable drug-eluting devices such as SynchroMed II intrathecal drug delivery system with controlled workflow system, plays an effective role in reducing or eliminate the use of oral opioids.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-10671

Antiretroviral (ARV) drug implant is expected to emerge as a promising approach for HIV treatment and prevention

In July 2022, Merck & Co. started the development of slow-release antiretroviral (ARV) drug implant as a promising approach for HIV treatment.

Medical-Pharma Collaborating to Balance Demand and Supply

A comprehensive view of the implantable drug-eluting devices market has led our analysts to conclude that, the market is expected to grow with an impressive rate. This market growth is mainly attributed due to increasing innovations and developments in implantable drug-eluting devices for the management and treatment of breast cancer, schizophrenia, Parkinson’s disease, and photosensitivity diseases. Besides, FMI analyst suggests that markets in North America and Europe are expected to hold major value shares in global implantable drug-eluting devices landscape. To cater to rising demand for implantable drug-eluting devices, medical device companies are collaborating with pharmaceutical companies for the development of efficient drug delivery devices.

Increasing use of syringe-based subcutaneous implantable drug-eluting devices is anticipated to minimize the number of invasive surgical procedures. Introduction of implantable drug-eluting devices or rare conditions such as central precocious puberty (CPP) will emerge as an important factor shaping the market for implantable drug-eluting devices.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-10671

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Due to the technological advancement in multichannel monitors, demand for multipara, multichannel transcutaneous monitors is increasing day by day. Despite channel limitations and lack of technological advancements, single channel transcutaneous monitors are likely to garner significant traction in developing countries, in the view of relatively large difference in price as compared to multi-channel transcutaneous monitors.

Multichannel Transcutaneous Monitors to Show Higher Opportunities for New Players

In recent years, the transcutaneous monitors market has been witnessing significant growth, on the back of wide availability of advanced and multi-channel transcutaneous monitors for patient monitoring. The multi-channel transcutaneous monitors involves simultaneous measurement of the ECG, brain functioning, blood gas measurement, and hemoglobin level. Due to rising demand for technologically advanced medical devices, healthcare professionals are giving more priority to buy multichannel transcutaneous monitors. As compared to single-channel transcutaneous monitors, multichannel transcutaneous monitors are fast and provide accurate results. Companies, in the transcutaneous monitors market, are launching products with longer battery life and benchtop portability. Such factors are thus expected to enhance the growth of the transcutaneous monitors market in coming years.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-4980

Market Players to Make Two-Fold Investments in APAC  

The APAC region has more demand for the transcutaneous monitors, due to growing number of hospitals and rising regional government initiatives towards public healthcare program. In the APAC region, South Asian countries including India have more number of hospitals. The mounting number of hospitals is expected to create additional demand for transcutaneous monitors in the future. In addition, growing number of local market players operating in countries such as China is expected to intensify the competition in the transcutaneous monitors market in the coming years.

The transcutaneous monitors market is expected to continue sustaining high demand for multichannel transcutaneous monitors, finds the report. As per FMI’s study, significant sales opportunities for the transcutaneous monitors market players are expected in the APAC & Latin America, owing to robust development in healthcare sectors along with favorable government policies for reduced cost of treatment. Also, there are opportunities in the APAC transcutaneous monitors market for new players, including tax exemption for the first three years.

FMI completed a deep study on transcutaneous monitors by keeping the breadline view in mind about the market CAGR and value share analysis. During the transcutaneous monitors market study, we also studied the top manufacturers’ differential strategies & supply chain parameters. The giant players such as Masimo & Danaher Corporation are focusing on enhancing their product portfolios through the launch of new technology in the transcutaneous monitors market and patented technology in the patient monitoring field. These developmental activities implemented by the top players will remain key to gaining distinct competitive edge in the market.

According to the report, the manufacturer are targeted towards innovations in the continuous patient monitoring field. Some innovations include the overnight patient transcutaneous gas monitors and auto-sleep mode patient monitors. They are the latest monitors with longer battery life and wireless capacity. Some monitors can further work on the smartphone-based application which can help monitor remote-based patients. For the neonate’s care, companies are launching the transcutaneous monitors with gold plated sensors compatibility and better accuracy.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-4980

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com